CRDF - Cardiff Oncology EPS misses by $0.05 beats on revenue February, 25 2021 05:20 PM Cardiff Oncology Inc. Cardiff Oncology (CRDF): Q4 GAAP EPS of -$0.19 misses by $0.05.Revenue of $0.12M (+33.3% Y/Y) beats by $0.09M.Press Release For further details see: Cardiff Oncology EPS misses by $0.05, beats on revenue